These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 39826)

  • 1. Advantages and disadvantages of low-dose oral contraceptives.
    Law B
    Int J Gynaecol Obstet; 1978-1979; 16(6):556-60. PubMed ID: 39826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical dosages for oral contraceptives.
    Mladenović D; Grcić R; Pestelek B; Kapor M
    J Int Med Res; 1977; 5(4):276-80. PubMed ID: 881099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology and common minor side effects of oral contraceptives.
    DeLia JE; Emery MG
    Clin Obstet Gynecol; 1981 Sep; 24(3):879-92. PubMed ID: 7026109
    [No Abstract]   [Full Text] [Related]  

  • 6. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J
    J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of an oral contraceptive.
    Langer A; Devanesan M; Pelosi MA; Apuzzio JJ; Frattarola M
    Am J Obstet Gynecol; 1976 Sep; 126(2):153-7. PubMed ID: 961755
    [No Abstract]   [Full Text] [Related]  

  • 10. Norgestrel, a low dose, oral progestogen for fertility contro. Supplementary report.
    Roland M; Friedman M; Hessekiel RJ
    Obstet Gynecol; 1968 May; 31(5):637-42. PubMed ID: 5646394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
    Lammers P; op ten Berg M
    Acta Obstet Gynecol Scand; 1991; 70(6):497-500. PubMed ID: 1837199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing contraceptive steroids and doses.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):57-62. PubMed ID: 6834349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H
    Acta Obstet Gynecol Scand; 1988; 67(2):171-4. PubMed ID: 2972160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogen-only pills and bleeding disturbances.
    Kovacs G
    Hum Reprod; 1996 Oct; 11 Suppl 2():20-3. PubMed ID: 8982741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic versus triphasic oral contraceptives for contraception.
    Van Vliet H; Grimes D; Helmerhorst F; Schulz K
    Cochrane Database Syst Rev; 2001; (4):CD003283. PubMed ID: 11687185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.